- 
                                        
digital.ahrq.gov/principal-investigator/cebul-randall
January 01, 2023 - Cebul, Randall  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Using electronic medical records to measure and improve performance. 
 
 
 
 Citation 
 Cebul RD. Using electronic medical records to measure and improve performance. Trans Am Clin Climatol Assoc 2008;119:65-76. 
 
 
 Principal Investigator 
 
 Cebul, Randall 
 
 
 
 Proj… 
                                     
                                                                    - 
                                        
digital.ahrq.gov/sites/default/files/docs/publication/uc1hs015359-bryant-final-report-2008.pdf
January 01, 2008 - inpatients with primary diagnosis of pressure ulcer was 
$836 million, not including secondary costs 
 
• Diabetic … included inpatients and outpatients with pressure ulcers of stage II, III, or IV, plus outpatients 
with diabetic
                                     
                                                                    - 
                                        
cds.ahrq.gov/sites/default/files/cds/artifact/1061/2024_CDS_Connect_IG_Diabetes_Part_One_Screening_0.pdf
January 01, 2024 - Exclusions “diabetes 
mellitus” 
Diagnosis of DM (both type 1 and type 2 because diabetic patients follow
                                     
                                                                    - 
                                        
digital.ahrq.gov/principal-investigator/ballard-david-j
January 01, 2023 - Ballard, David J.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Impact of Health Information Technology Implementation on Diabetes Process and Outcome Measures - Final Report 
 
 
 
 Citation 
 Ballard D. Impact of Health Information Technology Implementation on Diabetes Process and Outcome Measures - Final Report. (Prepared by Bay… 
                                     
                                                                    - 
                                        
www.uspreventiveservicestaskforce.org/uspstf/document/published-comment-and-response-do-lipid-lowering-agents-provide-a-greater-reduction-in-cardiovascular-events-among-patients-with-diabetes/diabetes-mellitus-type-2-in-adults-screening-2008
November 15, 2008 - Share to Facebook 
 
 
 
 
 
 Share to X 
 
 
 
 
 
 Share to WhatsApp 
 
 
 
 
 
 Share to Email 
 
 
 
 
 
 
 Print 
 
 
 
 
 
 
 archived 
 
 
 
 Published Comment and Response: Do Lipid-Lowering Agents Provide a Greater Reduction in Cardiovascular Events among Patients with Diabetes? 
 Diabetes Mellitus (Type 2) in… 
                                     
                                                                    - 
                                        
psnet.ahrq.gov/node/47711/psn-pdf
June 14, 2019 - Type 1 diabetes defined by severe insulin deficiency
occurs after 30 years of age and is commonly treated as
type 2 diabetes.
June 14, 2019
Thomas NJ, Lynam AL, Hill A, et al. Type 1 diabetes defined by severe insulin deficiency occurs after
30 years of age and is commonly treated as type 2 diabetes. Diabetologia.… 
                                     
                                                                    - 
                                        
hcup-us.ahrq.gov/reports/statbriefs/sb151.pdf
August 01, 2011 - In contrast, rates for short-term 
diabetes complications (i.e., diabetic ketoacidosis, hyperosmolarity
                                     
                                                                    - 
                                        
hcup-us.ahrq.gov/reports/statbriefs/sb102.jsp
December 01, 2010 - Statistical Brief #102 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 An official website of the Department of Health & Human Services 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Search All AHRQ Websites 
 
 
 Careers 
 
 
 Contact Us 
 
 
 Espanol 
 
 
 FAQs 
 
  Email Updates 
 
 
 
 
 … 
                                     
                                                                    - 
                                        
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
March 01, 2011 - Few studies used standard measures for diabetic
nephropathy and kidney function, such as
estimated glomerular
                                     
                                                                    - 
                                        
cds.ahrq.gov/sites/default/files/cds/artifact/1066/2024_CDS_Connect_IG_Diabetes_Part_Two_Counseling_1.pdf
January 01, 2024 - Diabetic patients fall under a 
different plan of care.
                                     
                                                                    - 
                                        
digital.ahrq.gov/sites/default/files/docs/resource/Mostashari_List_of_Measures_TCNY_AQA_eQARR_Crosswalk_1_30_08_Mostashari.pdf
June 16, 2021 - Core Measures TCNY AQA eQARR
Core Measures 
TCNY Measures AQA (included in TCNY 
Build) 
eQARR 2007   
Measure 
Name 
BRIEF 
DESCRIPTION 
OF MEASURE 
OR ALERT 
TRIGGER 
Measure 
Name 
BRIEF 
DESCRIPTION OF 
MEASURE OR 
ALERT TRIGGER 
Measure Name BRIEF 
DESCRIPTION OF 
MEASURE OR 
ALERT TRIGGER 
Assess 
tobac… 
                                     
                                                                    - 
                                        
hcup-us.ahrq.gov/reports/statbriefs/sb151.jsp
March 01, 2013 - In contrast, rates for short-term diabetes complications (i.e., diabetic ketoacidosis, hyperosmolarity
                                     
                                                                    - 
                                        
hcup-us.ahrq.gov/reports/statbriefs/sb17.jsp
November 17, 2006 - Statistical Brief #17 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 An official website of the Department of Health & Human Services 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Search All AHRQ Websites 
 
 
 Careers 
 
 
 Contact Us 
 
 
 Espanol 
 
 
 FAQs 
 
  Email Updates 
 
 
 
 
 
… 
                                     
                                                                    - 
                                        
hcup-us.ahrq.gov/reports/statbriefs/sb10.pdf
July 01, 2006 - lower-extremity amputations) 
– Diabetes, short-term complications (i.e., acute conditions such as diabetic
                                     
                                                                    - 
                                        
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
January 01, 2007 - Layout 1
Background 
Type 2 diabetes is characterized by insulin
resistance accompanied by progressive
deficiency in insulin secretion. Type 2
diabetes is an increasingly common disease
that is closely associated with obesity.  In
2005, the prevalence of Americans with
diagnosed type 2 diabetes was 2.4 percent
for ad… 
                                     
                                                                    - 
                                        
hcup-us.ahrq.gov/reports/statbriefs/sb10.jsp
July 10, 2006 - lower-extremity amputations) 
—	Diabetes, short-term complications (i.e., acute conditions such as diabetic
                                     
                                                                    - 
                                        
hcup-us.ahrq.gov/toolssoftware/comorbidity/Table1-FY2009-V3_4.pdf
April 01, 2009 - Microsoft Word - Table1-FY2009-V3_4.doc
Table 1. Changes Made to Comorbidity Software for FY2009, Version 3.4 
The following changes were made to the Comorbidity Software for fiscal year 2009. This year 
includes ICD-9-CM and MS-DRG V26 updates. These changes are incorporated in the tool 
currently available: Comorb… 
                                     
                                                                    - 
                                        
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary38/obesity-in-adults-screening-and-management-2012
October 15, 2011 - interventions, orlistat, and metformin all led to declines in fasting glucose levels in prediabetic and diabetic … 0.672 mmol/L [12.1 mg/dL]) greater than placebo]], possibly because those studies were conducted in diabetic … interventions (considered comparative effectiveness), including Look AHEAD, a weight-loss intervention trial in diabetic … Comparison of orlistat treatment and placebo in obese type 2 diabetic patients.
                                     
                                                                    - 
                                        
psnet.ahrq.gov/node/47509/psn-pdf
December 21, 2018 - Prevalence and predictors of delayed clinical diagnosis of
Type 2 diabetes: a longitudinal cohort study.
December 21, 2018
Gopalan A, Mishra P, Alexeeff SE, et al. Prevalence and predictors of delayed clinical diagnosis of Type 2
diabetes: a longitudinal cohort study. Diabet Med. 2018;35(12):1655-1662. doi:10.1111/… 
                                     
                                                                    - 
                                        
cds.ahrq.gov/sites/default/files/cds/artifact/1066/2023_Intervention_Content_T2DM_Part_Two_Counseling.xlsx
January 01, 2023 - Example Intervention Text
		Example Patient-Facing Intervention Text:  Prediabetes and Type 2 Diabetes: Part 2, Counseling
		General Information
The example intervention text shown below is embedded in the Clinical Quality Language (CQL) files for the Prediabetes and Type 2 Diabetes: Part 2, Counseling artifact.
Implem…